[Federal Register: October 4, 1999 (Volume 64, Number 191)]
[Notices]               
[Page 53749]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04oc99-81]                         

-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (99-124)]

 
Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of Prospective Patent License.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice that Fisk Ventures, Inc., of Racine, 
WI has applied for a partially exclusive license to practice the 
inventions described and claimed in U.S. Patent No. 5,153,132, entitled 
``Three-Dimensional Co-Culture Process;'' U.S. Patent No. 5,308,764, 
entitled ``Multi-Cellular Three-Dimensional Living Mammalian Tissue;'' 
U.S. Patent No. 5,330,908, entitled ``High Density Cell Culture 
System;'' U.S. Patent No. 4,839,046, entitled ``Bio-Reactor Chamber;'' 
U.S. Patent No. 5,002,890, entitled ``Spiral-Vane Bio-Reactor;'' U.S. 
Patent No. 5,155,034, entitled ``Three-Dimensional Cell to Tissue 
Assembly Process;'' U.S. Patent No. 5,627,021, entitled ``Multi-
Cellular, Three-Dimensional Living Mammalian Tissue;'' U.S. Patent No. 
5,496,722, entitled ``Cultured Normal Mammalian Tissue and Process;'' 
U.S. Patent No. 5,589,112, entitled ``Constructing a High-Density Cell 
Culture System;'' U.S. Patent No. 5,851,816, entitled ``Cultured High-
Fidelity Three Dimensional Human Urogenital Tract Carcinomas and 
Process;'' U.S. Patent No. 5,846,807, entitled ``Media Compositions for 
Three-Dimensional Mammalian Tissue Growth Under Microgravity Culture 
Conditions;'' U.S. Patent No. 5,858,783, entitled ``Production of 
Normal Mammalian Organ Culture Using a Medium Containing Mem-Alpha, 
Leibovitz L-15, Glucose Galactose Fructose;'' and in the pending U.S. 
Patent Application identified as NASA Case No. MSC-22122-1, entitled 
``Horizontal Rotating-Wall Vessel Propagation in Vitro Human Tissue 
Models.'' Each of the above U.S. Patents and the Patent Application are 
assigned to the United States of America as represented by the 
Administrator of the National Aeronautics and Space Administration. 
Partially exclusive license rights were also applied for in NASA's 
undivided interest in the U.S. Patent Application identified as NASA 
Case No. MSC-22859-1, entitled ``Production of Functional Proteins: 
Balance of Shear Stress and Gravity;'' and pending PCT application, 
NASA Case No. MSC-22859-1(PCT), entitled ``Production of Functional 
Proteins: Balance of Shear Stress and Gravity.'' Written objections to 
the prospective grant of a license should be sent to the Johnson Space 
Center.

DATES: Responses to this notice must be received by December 3, 1999.

FOR FURTHER INFORMATION CONTACT: James Cate, Patent Attorney, Johnson 
Space Center, Mail Stop HA, Houston, TX 77058-8452; telephone (281) 
483-1001.

    Dated: September 27, 1999.
Edward A. Frankle,
General Counsel.
[FR Doc. 99-25644 Filed 10-1-99; 8:45 am]
BILLING CODE 7510-01-P